Tau in the pancreas: understanding the link between type 2 diabetes mellitus and Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Tau in the pancreas: understanding the link between type 2 diabetes mellitus and Alzheimer’s disease ; volume:8 ; number:1 ; day:6 ; month:12 ; year:2023 ; pages:1-2 ; date:12.2023
Signal transduction and targeted therapy ; 8, Heft 1 (6.12.2023), 1-2, 12.2023

Classification: Medizin, Gesundheit

Creator: Li, Wenlu
Tiedt, Steffen
Lo, Eng H.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41392-023-01701-3

URN: urn:nbn:de:101:1-2024022214124215008013

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Li, Wenlu
Tiedt, Steffen
Lo, Eng H.
SpringerLink (Online service)

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau-related grey matter network breakdown across the Alzheimer’s disease continuum

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau-related grey matter network breakdown across the Alzheimer’s disease continuum

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau-related grey matter network breakdown across the Alzheimer’s disease continuum

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Tau in the pancreas: understanding the link between type 2 diabetes mellitus and Alzheimer’s disease

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau-related grey matter network breakdown across the Alzheimer’s disease continuum

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau-related grey matter network breakdown across the Alzheimer’s disease continuum

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau-related grey matter network breakdown across the Alzheimer’s disease continuum

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Related objects

Reset password